mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.002 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |